Cargando…

Pseudomonas aeruginosa Infections in Cancer Patients

Pseudomonas aeruginosa (P. aeruginosa) is one of the most frequent opportunistic microorganisms causing infections in oncological patients, especially those with neutropenia. Through its ability to adapt to difficult environmental conditions and high intrinsic resistance to antibiotics, it successfu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paprocka, Paulina, Durnaś, Bonita, Mańkowska, Angelika, Król, Grzegorz, Wollny, Tomasz, Bucki, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230571/ https://www.ncbi.nlm.nih.gov/pubmed/35745533 http://dx.doi.org/10.3390/pathogens11060679

Ejemplares similares

New β-Lactam Antibiotics and Ceragenins – A Study to Assess Their Potential in Treatment of Infections Caused by Multidrug-Resistant Strains of Pseudomonas aeruginosa
por: Paprocka, Paulina, et al.
Publicado: (2021)

Bactericidal Activity of Ceragenin in Combination with Ceftazidime, Levofloxacin, Co-Trimoxazole, and Colistin against the Opportunistic Pathogen Stenotrophomonas maltophilia
por: Paprocka, Paulina, et al.
Publicado: (2022)

Metallic Nanoparticles and Core-Shell Nanosystems in the Treatment, Diagnosis, and Prevention of Parasitic Diseases
por: Król, Grzegorz, et al.
Publicado: (2023)

Utility of blood procalcitonin concentration in the management of cancer patients with infections
por: Durnaś, Bonita, et al.
Publicado: (2016)

Ceragenin CSA-13 displays high antibacterial efficiency in a mouse model of urinary tract infection
por: Wnorowska, Urszula, et al.
Publicado: (2022)

Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development
por: Wątek, Marzena, et al.
Publicado: (2019)

Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome
por: Wollny, Tomasz, et al.
Publicado: (2021)

Sphingosine-1-Phosphate Metabolism and Its Role in the Development of Inflammatory Bowel Disease
por: Wollny, Tomasz, et al.
Publicado: (2017)

Recombinant Human Plasma Gelsolin Stimulates Phagocytosis while Diminishing Excessive Inflammatory Responses in Mice with Pseudomonas aeruginosa Sepsis
por: Piktel, Ewelina, et al.
Publicado: (2020)

Ceragenins and Ceragenin-Based Core-Shell Nanosystems as New Antibacterial Agents against Gram-Negative Rods Causing Nosocomial Infections
por: Karasiński, Maciej, et al.
Publicado: (2023)

Hypogelsolinemia in Patients Diagnosed with Acute Myeloid Leukemia at Initial Stage of Sepsis
por: Wątek, Marzena, et al.
Publicado: (2019)

Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia
por: Wątek, Marzena, et al.
Publicado: (2017)

Plasma Gelsolin: Indicator of Inflammation and Its Potential as a Diagnostic Tool and Therapeutic Target
por: Piktel, Ewelina, et al.
Publicado: (2018)

Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo
por: Durnaś, Bonita, et al.
Publicado: (2017)

Core–shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins
por: Niemirowicz, Katarzyna, et al.
Publicado: (2016)

Biofilm Growth Causes Damage to Silicone Voice Prostheses in Patients after Surgical Treatment of Locally Advanced Laryngeal Cancer
por: Spałek, Jakub, et al.
Publicado: (2020)

Use of ceragenins as a potential treatment for urinary tract infections
por: Wnorowska, Urszula, et al.
Publicado: (2019)

Bactericidal and immunomodulatory properties of magnetic nanoparticles functionalized by 1,4-dihydropyridines
por: Niemirowicz-Laskowska, Katarzyna, et al.
Publicado: (2018)

Sphingosine-1-Phosphate-Triggered Expression of Cathelicidin LL-37 Promotes the Growth of Human Bladder Cancer Cells
por: Wollny, Tomasz, et al.
Publicado: (2022)

Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13
por: Niemirowicz, Katarzyna, et al.
Publicado: (2017)

Hypogelsolinemia and Decrease in Blood Plasma Sphingosine-1-Phosphate in Patients Diagnosed with Severe Acute Pancreatitis
por: Wollny, Tomasz, et al.
Publicado: (2021)

Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy
por: Piktel, Ewelina, et al.
Publicado: (2016)

How to manage Pseudomonas aeruginosa infections
por: Bassetti, Matteo, et al.
Publicado: (2018)

Gold-functionalized magnetic nanoparticles restrict growth of Pseudomonas aeruginosa
por: Niemirowicz, Katarzyna, et al.
Publicado: (2014)

Two Lineages of Pseudomonas aeruginosa Filamentous Phages: Structural Uniformity over Integration Preferences
por: Fiedoruk, Krzysztof, et al.
Publicado: (2020)

Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics
por: Bucki, Robert, et al.
Publicado: (2018)

Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites
por: Durnaś, Bonita, et al.
Publicado: (2016)

Vaccination against respiratory Pseudomonas aeruginosa infection
por: Grimwood, Keith, et al.
Publicado: (2014)

Emerging therapies against infections with Pseudomonas aeruginosa
por: Tümmler, Burkhard
Publicado: (2019)

Airway immunometabolites fuel Pseudomonas aeruginosa infection
por: Riquelme, Sebastián A., et al.
Publicado: (2020)

Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics
por: Wood, Stephen J., et al.
Publicado: (2023)

Pseudomonas aeruginosa Biofilms
por: Thi, Minh Tam Tran, et al.
Publicado: (2020)

Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer
por: Markou, Panayiota, et al.
Publicado: (2014)

Management of refractory Pseudomonas aeruginosa infection in cystic fibrosis
por: Sordé, Roger, et al.
Publicado: (2011)

Resistance of Pseudomonas Aeruginosa
por: Graevenitz, Alexander Von
Publicado: (1977)

Impact of Pseudomonas aeruginosa Infection on Patients with Chronic Inflammatory Airway Diseases
por: Garcia-Clemente, Marta, et al.
Publicado: (2020)

The Role of Cathelicidin LL-37 in Cancer Development
por: Piktel, Ewelina, et al.
Publicado: (2015)

Vaccination to Prevent Pseudomonas aeruginosa Bloodstream Infections
por: Hart, Robert J., et al.
Publicado: (2022)

The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
por: Reynolds, Dan, et al.
Publicado: (2021)

Metallic Nanosystems in the Development of Antimicrobial Strategies with High Antimicrobial Activity and High Biocompatibility
por: Skłodowski, Karol, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h5j0th950pqbub2hflvptstotp